World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
33250
World Ranking
16918
National Ranking
888

Overview

Kurt Miller is affiliated with Charité - University Medicine Berlin in Germany. Their research primarily spans the field of Medicine with a particular focus on several subfields, including Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Surgery, Oncology, and Urology.

Their research topics notably cover:

  • Prostate Cancer Treatment and Research
  • Radiopharmaceutical Chemistry and Applications
  • Prostate Cancer Diagnosis and Treatment
  • Bladder and Urothelial Cancer Treatments
  • Urinary Bladder and Prostate Research
  • Cancer Immunotherapy and Biomarkers
  • Pelvic floor disorders treatments

Miller has contributed to significant research outputs over the years. Some of the recent papers include:

  • Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United States (2020) published in Clinical Genitourinary Cancer
  • Pasotuxizumab, a Bite ® Immune Therapy for Castration-Resistant Prostate Cancer: Phase I, Dose-Escalation Study Findings (2020) published in Immunotherapy
  • Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer (2022) published in JAMA Oncology
  • Transurethral en bloc submucosal hydrodissection vs conventional resection for resection of non-muscle-invasive bladder cancer (HYBRIDBLUE): a randomised, multicentre trial (2020) published in British Journal of Urology
  • Clinical outcomes and treatment patterns in REASSURE: planned interim analysis of a real-world observational study of radium-223 in metastatic castration-resistant prostate cancer (2023) published in EClinicalMedicine

Their frequent co-authors include:

  • Celestia S. Higano
  • Laura Wiemer
  • Fred Saad
  • Bertrand Tombal
  • Oliver Sartor

In terms of publication venues, Miller has consistently contributed to:

  • Aktuelle Urologie
  • Journal of Clinical Oncology
  • Prostate Cancer and Prostatic Diseases
  • Journal of Clinical Medicine
  • Therapeutics and Clinical Risk Management

Best Publications

  • Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

    Howard I. Scher;Karim Fizazi;Fred Saad;Mary-Ellen Taplin

  • Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

    Tomasz M Beer;Andrew J Armstrong;Dana E Rathkopf;Yohann Loriot

  • Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95

    Thomas Wiegel;Dirk Bottke;Ursula Steiner;Alessandra Siegmann

  • Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study

    Charles J. Ryan;Matthew R. Smith;Karim Fizazi;Fred Saad

  • Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer : results of a phase 3, randomised, placebo-controlled trial.

    Matthew R Smith;Fred Saad;Robert Coleman;Neal Shore

  • Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.

    Annika Schaefer;Monika Jung;Hans-Joachim Mollenkopf;Ina Wagner

  • The ileal neobladder

    Hautmann Re;Egghart G;Frohneberg D;Miller K

  • Adjuvant Radiotherapy Versus Wait-and-See After Radical Prostatectomy: 10-year Follow-up of the ARO 96–02/AUO AP 09/95 Trial

    Thomas Wiegel;Detlef Bartkowiak;Dirk Bottke;Claudia Bronner

  • Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study.

    Tomasz M. Beer;Andrew J Armstrong;Dana E Rathkopf;Yohann Loriot

  • Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial.

    Matthew Smith;Chris Parker;Fred Saad;Kurt Miller

  • Sarcosine in Urine after Digital Rectal Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours

    Florian Jentzmik;Carsten Stephan;Kurt Miller;Mark Schrader

  • Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial

    Fred Saad;Joan Carles;Silke Gillessen;Axel Heidenreich

  • Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations

    E. David Crawford;Axel Heidenreich;Axel Heidenreich;Nathan Lawrentschuk;Bertrand Tombal

  • Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study

    Hubert Kübler;Birgit Scheel;Ulrike Gnad-Vogt;Kurt Miller

  • A Multicenter Randomized Noninferiority Trial Comparing GreenLight-XPS Laser Vaporization of the Prostate and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: Two-yr Outcomes of the GOLIATH Study

    James A. Thomas;Andrea Tubaro;Neil Barber;Frank d’Ancona

  • Phase III, Randomized, Placebo-Controlled Study of Docetaxel in Combination With Zibotentan in Patients With Metastatic Castration-Resistant Prostate Cancer

    Karim S. Fizazi;Celestia S. Higano;Joel B. Nelson;Martin Gleave

  • Denosumab and Bone Metastasis–Free Survival in Men With Nonmetastatic Castration-Resistant Prostate Cancer: Exploratory Analyses by Baseline Prostate-Specific Antigen Doubling Time

    Matthew R. Smith;Fred Saad;Stephane Oudard;Neal Shore

  • 180-W XPS GreenLight Laser Vaporisation Versus Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: 6-Month Safety and Efficacy Results of a European Multicentre Randomised Trial—The GOLIATH Study

    Alexander Bachmann;Andrea Tubaro;Neil Barber;Frank d’Ancona

  • Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1

    Matthew Smith;Johann De Bono;Cora Sternberg;Sylvestre Le Moulec

  • Systemic therapy in metastatic renal cell carcinoma

    Jens Bedke;Thomas Gauler;Viktor Grünwald;Axel Hegele

Frequent Co-Authors

Fred Saad
Fred Saad University of Montreal
Carsten Stephan
Carsten Stephan Charité - University Medicine Berlin
Cora N. Sternberg
Cora N. Sternberg Cornell University
Karim Fizazi
Karim Fizazi University of Paris-Saclay
Celestia S. Higano
Celestia S. Higano University of Washington
Bertrand Tombal
Bertrand Tombal Université Catholique de Louvain
Neal D. Shore
Neal D. Shore Carolina Urologic Research Center
Axel Heidenreich
Axel Heidenreich University of Cologne
Johann S. de Bono
Johann S. de Bono Institute of Cancer Research
Peter F.A. Mulders
Peter F.A. Mulders Radboud University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring a future in healthcare beyond traditional medicine, many flexible online degree options can help you enter or advance in growing fields. For those interested in patient care without lengthy admissions processes, consider enrolling in a nursing school that does not require teas test. These programs streamline the path to becoming a Registered Nurse and open doors to meaningful roles.

Administrative leadership is also a vital part of healthcare. An online healthcare administration associate degree online can quickly prepare you for opportunities in hospital or clinic management—often in as little as two years. If you’re a working nurse with an associate degree, ADN to MSN bridge programs offer a direct, accelerated path to advanced practice and leadership. Explore your options with adn to msn bridge programs.

Another emerging field is nutrition, pivotal for preventive health and wellness. Launch your career by enrolling in an online bachelor's degree in nutrition, opening diverse pathways in public health, wellness coaching, and clinical settings.

Best Scientists Citing Kurt Miller

Trending Scientists

Recently Published Articles